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High frequency of neurologic diseases including urinary
symptoms of overactive bladder (OAB) have been docu-
mented in HTLV-1 infected subjects. Moreover OAB
may be the initial manifestation of HTLV-1 associated
myelopathy (HAM). The aim of this study was to evalu-
ate the immune response, proviral load and plasma
levels of soluble Interleukin-2 receptor (sIL-2R) and beta
2 microglobulin (b2M) in HTLV-1 carriers, patients
with HTLV-1 OAB and in patients with HAM to deter-
mine if these parameters are markers of neurologic dis-
ease. Cells and serum from carriers, HTLV-1 OAB and
HAM/TSP patients were used. HAM/TSP had higher
levels of b2M and sIL-2R than HTLV-1 OAB and car-
riers. Cells from HTLV-1 OAB produced spontaneously
more proinflammatory cytokines than carriers. TNF-a
and IL-17 expression as well as proviral load were simi-
lar in HAM/TSP and HTLV-1 OAB and were higher
than in carriers. In contrast to HAM/TSP, levels of Th1
chemokines were similar in HTLV-1 OAB and carriers.
Different from HAM/TSP addition of regulatory cyto-
kines in cell cultures from HTLV-1 OAB decreased
spontaneous IFN-g. This study showed that while sIL-
2R determination helps in identifying HAM/TSP, both
sIL-2R and b2M did not help to monitor neurologic dis-
ease progression. Additionally we showed that HTLV-1
OAB and HAM/TSP have in common many immunologi-
cal features as well as proviral load. However, as HTLV-1
OAB were still able to down regulate their inflammatory
response and express levels of chemokines similar to car-
riers this may explain why they have not yet developed the
spinal cord damage observed in HAM/TSP.
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